![]() ABCZF 19 Mar 2020 Paid | Other | $0.04 Per Share |
![]() ABCZF 7 Nov 2019 Paid | Other | $0.11 Per Share |
![]() ABCZF 14 Mar 2019 Paid | Other | $0.04 Per Share |
![]() ABCZF 8 Nov 2018 | Other | $0.09 Per Share |
![]() ABCZF 15 Mar 2018 | Other | $0.03 Per Share |
31 Dec 2016 Date | | - Cons. EPS | 0.06 EPS |
30 Sep 2016 Date | | - Cons. EPS | 0.06 EPS |
30 Jun 2016 Date | | - Cons. EPS | 0.07 EPS |
31 Mar 2016 Date | | - Cons. EPS | 0.07 EPS |
31 Dec 2015 Date | | - Cons. EPS | 0.06 EPS |
![]() ABCZF 19 Mar 2020 Paid | Other | $0.04 Per Share |
![]() ABCZF 7 Nov 2019 Paid | Other | $0.11 Per Share |
![]() ABCZF 14 Mar 2019 Paid | Other | $0.04 Per Share |
![]() ABCZF 8 Nov 2018 | Other | $0.09 Per Share |
![]() ABCZF 15 Mar 2018 | Other | $0.03 Per Share |
31 Dec 2016 Date | | - Cons. EPS | 0.06 EPS |
30 Sep 2016 Date | | - Cons. EPS | 0.06 EPS |
30 Jun 2016 Date | | - Cons. EPS | 0.07 EPS |
31 Mar 2016 Date | | - Cons. EPS | 0.07 EPS |
31 Dec 2015 Date | | - Cons. EPS | 0.06 EPS |
Biotechnology Industry | Healthcare Sector | Mr. Markus Lusser CEO | OTC PINK Exchange | GB00B6774699 ISIN |
GB Country | 1,760 Employees | 7 Nov 2019 Last Dividend | - Last Split | - IPO Date |
Abcam plc is a distinguished life science company established in 1998 with its headquarters in Cambridge, the United Kingdom. The company has carved a niche for itself by focusing on the identification, development, and distribution of essential reagents and tools needed for scientific research, diagnostics, and drug discovery. Abcam plc caters to a diverse clientele, including scientists and researchers in academic institutions and research institutes, as well as those in pharmaceutical, biotechnology, and diagnostics companies. With operations spanning across the Americas, Europe, the Middle East, Africa, China, Japan, and the rest of the Asia Pacific, the company has established a global footprint. Abcam plc stands out for its strategic approach to product distribution by leveraging online sales channels, thereby enhancing accessibility and convenience for its global customer base. As of December 6, 2023, the company became a subsidiary of Danaher Corporation, marking a significant milestone in its evolution and highlighting its value and impact in the life science industry.
Abcam plc offers an extensive range of products and services designed to meet the varied needs of the scientific research community. These include:
By providing these comprehensive products and services, Abcam plc significantly contributes to advancing scientific discoveries and innovations in various research fields.